Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial

Clinical trial NCT05165225 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05165225
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer HER2-low-expressing Breast Cancer Hormone Receptor-positive Breast Cancer Neoadjuvant Therapy

Start date: 2021-07-13
Primary completion: 2023-09-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.